Breaking bones is unfortunately a common part of life; in fact doctors treat about 6.8 million fractures each year in the United States alone, and the average person can expect to sustain two fractures over their lifetime. 

In this episode, we are joined by Brian Hess, CEO and Founder of RevBio, who is helping to transform bone repair with their innovative adhesive. Not only is this solution boosting how bones can rapidly fuse back together through its biomimicry properties, this is a product that stimulates bone growth and leaves no artifact in the body.

From raising nearly $20 million in non-dilutive funding, it’s clear that this technology has huge potential with multiple indications available to be applied to. Brian lays out a clear strategic path to market that includes the opportunity to leverage early animal studies with veterinarians also seeing significant value from this exciting technology in the near term.

Throughout this discussion, Brian displays all the attributes of a great leader, with a top co-founder coupled alongside in Grayson Allen, they have developed a winning culture, and a team that thrives on the opportunities they are given to both develop personally and help take this product to market.

As a UMass M2D2 resident, RevBio is able to access a number of resources and an incredible pipeline of young talented interns who have grown with the company and stepped up into more senior roles. This is a startup story that is packed full of the hallmarks for building a successful innovative medical solution, and one that is sure to leave you informed and inspired.